Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
How Bioinformatics is Boosting Precision Medicine
Posted on January 9th, 2017 by Christy J. Wilson in Pharma R&D
Although the pharmaceutical industry has invested a great deal in data-producing technologies (e.g. next-generation and single cell sequencing), it has been slower to invest in the data management and analytics technologies that are needed to actually draw insights and information from all that data. Areas where these important investments in management have been made, however, are starting to see some noteworthy results.
For instance, bioinformatics tools are already helping R&D teams quickly mine data from literature that helps them repurpose drugs to treat the sorts of rare diseases that affect millions of people but have historically gone ignored. Bioinformatics solutions, which can include tools like natural language processing software, are also being successfully utilized to accelerate immunotherapy development and to improve microbiome analyses.
Read this article to find out more about how bioinformatics, such as the burgeoning field of translational bioinformatics, will continue driving precision medicine into the future.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Christy J. Wilson
Sr. Director, Pharma and Biotech Segment
Connect on LinkedIn
Follow on Twitter
- Assessing DDI Risk in the Digital Age
- The Link Between Big Pharma and the Supplement Industry
- Maryland Attempts to Control Drug Prices
- Biosimilars Development & its Future
- Advantages and Challenges of Using Social Media for Pharma R&D